FUJIFILM Holdings Corp

MarketsandMarkets projects the global MRI systems market will grow from USD 6.88 billion in 2026 to USD 9.68 billion by 2031, at a CAGR of 7.0%. Growth is driven by the rising prevalence of neurological and musculoskeletal disorders, an expanding geriatric population, increasing chronic diseases like cancer, and supportive regulatory and reimbursement policies. The closed MRI systems segment held the largest market share in 2025, as did the fixed/stationary design segment. Asia Pacific is experiencing rapid growth, particularly in China, India, and Southeast Asia. Key players include Siemens Healthineers, GE HealthCare, Philips, FUJIFILM, and Canon, with innovations focusing on AI-enabled workflows and helium-free systems.

Fujifilm North America Corporation announced the launch of 'Fujifilm for Google Photos Print Store,' a new integrated print storefront that brings high-quality physical photo products directly to Google Photos users. Fujifilm will take over leadership and responsibility for the photo printing functionality of the platform, including full storefront management, customer support, customer lifecycle marketing, and an expanded product catalog, while continuing its partnership with Google Photos. The new storefront will offer an expanded range of print formats, frames, décor, and gift items, and will leverage Google Photos' intelligence to suggest personalized print opportunities. The platform began rolling out to U.S. users at the end of August 2026, and will be available to both current and new Google Photos users.

The global robotic endoscopy devices market is projected to grow from $2.8 billion in 2025 to $6.5 billion by 2034, at a compound annual growth rate of approximately 10%, according to a report by DelveInsight. North America accounted for about 42% of global revenue in 2025, driven by widespread adoption of robotic-assisted surgical technologies and the presence of major players such as Intuitive Surgical, Medtronic, and Johnson & Johnson MedTech. The therapeutic robotic endoscopes category was the largest product segment, while the Asia-Pacific region is expected to see the highest growth due to aging populations and rising investments in robotic surgery. Key companies in the market include Intuitive Surgical, Johnson & Johnson MedTech, Medtronic, Olympus, Boston Scientific, FUJIFILM, Stryker, KARL STORZ, Asensus Surgical, and CMR Surgical. Recent developments include FDA clearance of Medtronic's Hugo system for urologic procedures in December 2025 and FDA 510(k) clearance of CMR Surgical's Versius Plus system for cholecystectomy.

Nvidia is widening its reach across Japan's largest industries. During a visit to Tokyo, CEO Jensen Huang announced partnerships covering robotics, health care, banking, manufacturing, automobiles, quantum computing and gaming. Japanese companies including FANUC, Sony, Hitachi, Kubota and SoftBank plan to work with Nvidia on physical AI models for robots and industrial systems. In health care, several drugmakers are using Nvidia's BioNeMo platform for drug discovery, while Canon and Fujifilm introduced medical imaging systems built with Nvidia technology. Toyota is expanding its work with Nvidia on driver-assistance software, factory simulations and traffic systems, Mizuho and Sumitomo Mitsui are building AI infrastructure for banking, and RIKEN is preparing Blackwell-powered supercomputers for scientific and quantum research.

Nvidia CEO Jensen Huang unveiled a broad slate of AI products, partnerships, and customer deployments at the company's Japan AI event in Tokyo on July 15. The announcements spanned physical AI, healthcare, financial services, quantum computing, automotive, manufacturing, and gaming, highlighting Nvidia's push to position its technologies at the forefront of Japan's next-generation AI infrastructure. In physical AI and robotics, Nvidia launched Cosmos 3 Edge for on-device vision reasoning, and companies including FANUC, Fujitsu, Hitachi, Kawasaki Heavy Industries, Kubota, NEC, SoftBank, Sony Group, and Yaskawa Electric plan to join the Nvidia Cosmos Coalition to develop open physical AI models. In healthcare, Astellas Pharma, Eisai, Daiichi Sankyo, Ono Pharmaceutical, and Takeda Pharmaceutical are deploying Nvidia BioNeMo for AI-powered drug discovery, while Canon and Fujifilm introduced Nvidia-powered next-generation CT systems, and Kawasaki Heavy Industries is advancing AI-enabled surgical and hospital robots. In financial services, Mizuho Financial plans Japan's largest on-premises AI factory for banking, Sumitomo Mitsui Financial has deployed an AI factory through Japan Research Institute, and Rakuten Bank is developing AI transaction foundation models using Nvidia Agent Toolkit. Huang emphasized that the next wave of AI will be physical AI—robots, factories, vehicles, and industrial systems that can perceive, reason, and act in the real world—and said Japan's leadership in robotics, manufacturing, and precision engineering positions it to play a leading role in this transition.

Fujifilm's lens-fitted film camera 'Utsurundesu' marks its 40th anniversary, with the analog photography experience regaining popularity, especially among young people. The first model was released on July 1, 1986, priced at 1,380 yen, and cumulative sales have exceeded 1.7 billion units. Sales peaked around 1997 but declined with the spread of digital cameras and mobile phones. However, popularity has resurged since the late 2010s. At Don Quijote stores, sales have been climbing since the pandemic, and Loft experienced temporary stock shortages. Starting in August, Fujifilm will launch its first new products in 20 years: a waterproof model priced around 4,480 yen and a black-and-white film model priced around 4,300 yen.